| [1] |
陆苏, 刘红 . 44例隐匿性乳腺癌临床分析[J]. 中华肿瘤杂志, 2011,33(7):550-552. DOI: 10.3760/cma.j.issn.0253-3766.2011.07.018.
|
| [2] |
Halsted WS . The results of radical operations for the cure of carcinoma of the breast[J]. Ann Surg, 1907,46(1):1-19. DOI: 10.1097/00000658-190707000-00001.
|
| [3] |
Lu H, Xu YL, Zhang SP , et al. Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings[J]. Chin Med J (Engl), 2011,124(12):1790-1795. DOI: 10.3760/cma.j.issn.0366-6999.
|
| [4] |
李小康, 徐熠琳, 刘佩芳 , 等. 乳腺MRI在X线检查乳腺阴性腋淋巴结转移癌阳性患者中的应用价值[J]. 中华放射学杂志, 2011,45(4):348-352. DOI: 10.3760/cma.j.issn.1005-1201.2011.04.006.
|
| [5] |
Maselli-Schoueri JH, Affonso-Kaufman FA, de Melo Sette CV, , et al. Time trend of breast cancer mortality in BRAZILIAN men: 10-year data analysis from 2005 to 2015[J]. BMC Cancer, 2019,19(1):23. DOI: 10.1186/s12885-018-5261-1.
|
| [6] |
Agbroko SO, Rojas KE, Manasseh DM , et al. Male DCIS diagnosed after use of over-the-counter hormonal supplement[J]. Int J Surg Case Rep, 2019,57:60-62. DOI: 10.1016/j.ijscr.2019.02.028.
|
| [7] |
Barghouthi N, Turner J, Perini J , et al. Breast cancer development in a transgender male receiving testosterone therapy[J]. Case Rep Endocrinol, 2018,2018:602. DOI: 10.1155/2018/3652602.
|
| [8] |
Rizzolo P, Zelli V, Silvestri V , et al. Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy[J]. Int J Cancer, 2019,145(2):390-400. DOI: 10.1002/ijc.32106.
|
| [9] |
马家芳, 乔昱, 丁丽 , 等. 男性乳腺癌患者临床病理特征及诊治分析[J]. 中华老年医学杂志, 2015,34(7):790-792. DOI: 10.3760/cma.j.issn.0254-9026.2015.07.026.
|
| [10] |
Xu R, Li J, Zhang Y , et al. Male occult breast cancer with axillary lymph node metastasis as the first manifestation[J]. Medicine (Baltimore), 2017,96(51):e9312. DOI: 10.1097/MD.00000000-00009312.
|
| [11] |
Ruddy KJ, Winer EP . Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship[J]. Ann Oncol, 2013,24(6):1434-1443. DOI: 10.1093/annonc/mdt025.
|
| [12] |
Bateni SB, Davidson AJ, Arora M , et al. Is breast-conserving therapy appropriate for male breast cancer patients? A national cancer database analysis[J]. Ann Surg Oncol, 2019,26(7):2144-2153. DOI: 10.1245/s10434-019-07159-4.
|
| [13] |
Wei JL, Zhang JX, Fu DY , et al. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study[J]. World J Surg Oncol, 2018,16(1):236. DOI: 10.1186/s12957-018-1539-7.
|
